1. Wider, C, Vilariño-Güell, C, Heckman, M G, Farrer, M J, Ross, O A. 2010. SNCA, MAPT, and GSK3B in Parkinson disease: a gene-gene interaction study. In European journal of neurology, 18, 876-81. doi:10.1111/j.1468-1331.2010.03297.x. https://pubmed.ncbi.nlm.nih.gov/21159074/
2. Hamanaka, Kohei, Miyake, Noriko, Mizuguchi, Takeshi, Takata, Atsushi, Matsumoto, Naomichi. 2022. Large-scale discovery of novel neurodevelopmental disorder-related genes through a unified analysis of single-nucleotide and copy number variants. In Genome medicine, 14, 40. doi:10.1186/s13073-022-01042-w. https://pubmed.ncbi.nlm.nih.gov/35468861/
3. Chen, Jianhua, Wang, Meng, Waheed Khan, Raja Amjad, Shi, Yongyong, Ji, Weidong. 2015. The GSK3B gene confers risk for both major depressive disorder and schizophrenia in the Han Chinese population. In Journal of affective disorders, 185, 149-55. doi:10.1016/j.jad.2015.06.040. https://pubmed.ncbi.nlm.nih.gov/26186530/
4. Zhu, Ming-Chuang, Zhang, Yan-Hong, Xiong, Peng, Li, Guo-Liang, Zhu, Min. 2022. Circ-GSK3B up-regulates GSK3B to suppress the progression of lung adenocarcinoma. In Cancer gene therapy, 29, 1761-1772. doi:10.1038/s41417-022-00489-8. https://pubmed.ncbi.nlm.nih.gov/35821283/
5. Wang, Ruoyu, Tang, Dan, Ou, Longyun, Wu, Yu-Nan, Tian, Xuefei. 2024. β-Sitosterol alleviates the malignant phenotype of hepatocellular carcinoma cells via inhibiting GSK3B expression. In Human cell, 37, 1156-1169. doi:10.1007/s13577-024-01081-y. https://pubmed.ncbi.nlm.nih.gov/38814517/
6. Kettunen, Petronella, Larsson, Susanna, Holmgren, Sandra, Nilsson, Staffan, Sjölander, Annica. . Genetic variants of GSK3B are associated with biomarkers for Alzheimer's disease and cognitive function. In Journal of Alzheimer's disease : JAD, 44, 1313-22. doi:10.3233/JAD-142025. https://pubmed.ncbi.nlm.nih.gov/25420549/
智鼠故事 
